In the “Great Drug Pricing Debate of 2016,” a semi-fictional duo goes head-to-head on whether the pricing of prescription drugs is spiraling out of control, whether price controls should be instituted, and whether drugs can be priced based on value.

Pricing practices for prescription drugs are drawing intense scrutiny from inside and outside the healthcare industry.

Healthcare payers are apoplectic over the rising costs of prescription drugs. America’s Health Insurance Plans, the trade association for healthcare payers, has been blasting pharmaceutical companies over drug pricing on a nearly daily basis.

Healthcare providers also are sounding the alarm, with the American Medical Association announcing in November that it would launch an “advocacy campaign to drive solutions and help make prescription drugs more affordable.”

Drug pricing is already a hot topic in this year’s presidential race, with Democratic Party contender Hillary Clinton calling for affordable drug pricing in political advertising and on her campaign’s website. Her main opponent, Sen. Bernie Sanders (D, VT) has his own plan to lower prescription drug prices.

Continue Reading on HealthLeadersMedia.com